ANCELEX

Serial Number 78448445
601

Registration Progress

Application Filed
Jul 9, 2004
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ANCELEX

Basic Information

Serial Number
78448445
Filing Date
July 9, 2004
Abandonment Date
September 13, 2004
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Nov 28, 2004
Classes
001 005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
371 Bel Marin Keys Boulevard
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Legal Representation

Attorney
Alisa C. Simmons

Application History

5 events
Date Code Type Description
Nov 29, 2004 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Nov 28, 2004 DOCK D ASSIGNED TO EXAMINER
Nov 28, 2004 ABN1 O ABANDONMENT - EXPRESS MAILED
Sep 13, 2004 MAIL I PAPER RECEIVED
Jul 19, 2004 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Assays, screening kits, devices, and equipment for scientific analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for scientific purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceutical preparations for treatment of inflammation, infectious diseases, cancer, lysosomal storage diseases, mucopolysaccharidoses, enzyme disorders, infections, respiratory diseases, pain, fever, cough, colds, skin diseases, and allergies; pharmaceutical preparations for treatment of endocrine, rheumatic, collagen, dermatologic, opthalmic, hematologic, euplastic, neoplastic, cardiovascular, gastrointestinal, neurological, metabolic, and genetic diseases and disorders; enzymes for use in disease treatment; enzymes for use in the treatment of fungal infections; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of medical conditions; assays, screening kits, devices, and equipment for medical anaylsis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for medical purposes;
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005

USPTO Documents

Loading USPTO documents...